Cytokeratin 7 Antikörper (N-Term)
Kurzübersicht für Cytokeratin 7 Antikörper (N-Term) (ABIN870434)
Target
Alle Cytokeratin 7 (KRT7) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 22-38, N-Term
-
Verwendungszweck
- Anti-Cytokeratin 7
-
Spezifität
- Cytokeratin 7
-
Immunogen
- Peptide derived from N-terminal sequence of human cytokeratin 7. Antibody recognizes the epitope between Ala22 - Ser38.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- 1:100 - 200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 20 mM Tris-HCI, pH 8.0, Stabilizer: 20 mg/mL BSA, Preservative: 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- +2 °C to +8 °C
-
-
- Cytokeratin 7 (KRT7) (Keratin 7 (KRT7))
-
Andere Bezeichnung
- Cytokeratin 7
-
Hintergrund
- Low molecular weight cytokeratin. Its expression is restricted to the epithelia and theirs neoplasms. Overexpression of CK7 had been detected in the majority of epithelial carcinomas. It is successfully used in detection of renal cell carcinomas, ovarian metastatic carcinomas and in discriminating the primary pulmonary adenocarcinoma from metastatic adenocarcinoma.
-
UniProt
- P08729
Target
-